NEU neuren pharmaceuticals limited

Ann: Comment on research report, page-151

  1. 2,179 Posts.
    lightbulb Created with Sketch. 553
    It's pretty clear which company was the real target of the Report. The respective share price responses tell that story. Currently, Neuren with a vastly minor interest in Daybue, the relevant content of the Report, compared to Acadia's stake, sits at a hefty share price disadvantage. Makes no sense. Oh wait, Neuren is in discussions, Neuren has NNZ 2591, Neuren's shares are tightly held, oh...I get it.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.